EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations

Günay Husuzade, Burcu Demiralp iD, Hakan Nazlı iD, Tuğçe Boran, Sevgi Güngör iD

Pharmaceutics · 07.11.2025 · 17 (11) · 1436

DOI: 10.3390/pharmaceutics17111436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.11.2025. Verfasst von Günay Husuzade und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul 34116, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul University Scientific Research Project Department, Laborist, Istanbul University Scientific Research Projects Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This work aimed to enhance the solubility of Tadalafil (TDL), a BCS Class II drug, by preparing Type IV lipid-based formulations.

Methods

Type IV formulations were prepared using surfactants and/or hydrophilic co-surfactants, resulting in oil-free systems.

Results

Based on the solubility test, Transcutol® HP exhibited the highest solubility for TDL (48.33 ± 0.004 mg/mL) and was selected as the co-surfactant. Among surfactants, Kolliphor® PS80 (42.74 ± 2.29 mg/mL), Kolliphor® EL (41.87 ± 2.50 mg/mL), Kollisolv® PEG 400 (40.70 ± 0.30 mg/mL), and Kolliphor® HS15 (31.40 ± 3.63 mg/mL) demonstrated high solubilization capacity. These were used to prepare formulations without the addition of an oil phase. The developed formulations resulted in a system with a nano-droplet size (

Schlagwörter

Stichwörter der Autor:innen

Caco 2 cell lineTadalafilType IV lipid-based formulationsanalytical studieslipolysislow solubility

Autor:innen und Institutionen

  • Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul 34116, Türkiye.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Türkiye.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Trakya University, Edirne 22030, Türkiye.
  • Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul-Cerrahpaşa University, Istanbul 34320, Türkiye.

ORCID-Profile: Burcu Demiralp, Hakan Nazlı, Sevgi Güngör

Förderung

  • Istanbul University Scientific Research Project Department
  • Laborist
  • Istanbul University Scientific Research Projects Department

Zitieren

APA

Husuzade, G., Demiralp, B., Nazlı, H., Boran, T., & Güngör, S. (2025). Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations. Pharmaceutics, 17(11), 1436. https://doi.org/10.3390/pharmaceutics17111436

Vancouver

Husuzade G, Demiralp B, Nazlı H, Boran T, Güngör S. Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations. Pharmaceutics. 2025;17(11):1436. doi:10.3390/pharmaceutics17111436

BibTeX
@article{Husuzade2025,
  author = {Husuzade, Günay and Demiralp, Burcu and Nazlı, Hakan and Boran, Tuğçe and Güngör, Sevgi},
  title = {Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {11},
  pages = {1436},
  doi = {10.3390/pharmaceutics17111436}
}
Kostenlos starten →